Company Search:
Advanced Search
Sponsored Links
Scinopharm Taiwan Limited Company Snapshot
Scinopharm Taiwan Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Scinopharm Taiwan Limited with three other companies in this sector in Taiwan: Chunghwa Chemical Synthesis & Biotech Co Ltd (2016 sales of 1.20 billion Taiwanese Dollars [US$41.15 million] of which 53% was USA), Savior Lifetec Corp (1.53 billion Taiwanese Dollars [US$52.60 million] of which 100% was Drugs Development, Production and Sales), and Sci Pharmtech Inc (1.90 billion Taiwanese Dollars [US$65.33 million] of which 100% was Manufacture and Sale of Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at Scinopharm Taiwan Limited were 4.03 billion Taiwanese Dollars (US$138.38 million). This is a very small increase of 1.9% versus 2015, when the company's sales were 3.96 billion Taiwanese Dollars. Despite this increase, sales are still slightly below the level achieved in 2014, when Scinopharm Taiwan Limited reported sales of 4.10 billion Taiwanese Dollars. The sales level in 2016 was fairly close to the level five years ago: in 2011, Scinopharm Taiwan Limited had sales of 3.95 billion Taiwanese Dollars. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 145.1% in 2016, from 58.07 million Taiwanese Dollars to 142.31 million Taiwanese Dollars. Not all segments of Scinopharm Taiwan Limited experienced an increase in sales in 2016: sales of Taiwan Shenlong fell 0.2% to 3.89 billion Taiwanese Dollars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Scinopharm Taiwan Limited
  Stock Performance Chart for Scinopharm Taiwan Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 33.15
(Figures in Taiwanese Dollars)
1 Week 1.7%   13 Weeks 5.7%  
4 Weeks -6.9%   52 Weeks -22.5%  
Scinopharm Taiwan Limited Key Data:
  Ticker: 1789 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 4,030,921,000
(Year Ending Jan 2017).
Employees: 1,010
  Currency: Taiwanese Dollars Market Cap: 26,212,999,176
  Fiscal Yr Ends: December Shares Outstanding: 790,739,040
  Share Type: Gu Closely Held Shares: 471,094,280
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.